Viewing Study NCT06063200



Ignite Creation Date: 2024-05-06 @ 7:36 PM
Last Modification Date: 2024-10-26 @ 3:09 PM
Study NCT ID: NCT06063200
Status: RECRUITING
Last Update Posted: 2024-05-02
First Post: 2023-09-26

Brief Title: Methylphenidate and Response to Alcohol Cues
Sponsor: University of Florida
Organization: University of Florida

Study Overview

Official Title: Methylphenidate and Response to Alcohol Cues MARA Pilot Study
Status: RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine whether changes in attention levels related to taking a single dose of a medication called methylphenidate also known as Ritalin affects responses to alcohol cues The study will observe the effects of methylphenidate or a placebo on attentional bias and craving responses to alcohol cues through fMRI EEG and behavioral testing Participants will be involved in one remote and two in-person sessions
Detailed Description: Recent studies have revealed a robust link between attentional ability and resilience against stress-related psychopathology in general and against alcohol use disorder AUD specifically For example self-reported attentional ability correlates with scales of psychological resilience and with lower alcohol misuse in at-risk individuals One mechanism by which attention may relate to resilience in AUD is through its effects on alcohol cue reactivity Exposure to alcohol cues can induce motivation to drink alcohol for those with AUD Leveraging the high rates of co-morbidity of AUD and attention-deficithyperactivity disorder this pilot study seeks to demonstrate whether experimentally enhancing attention in individuals with both AUD and attentional deficits associated with attention-deficithyperactivity disorder ADHD reduces markers of addiction severity ie craving and attentional bias responses to alcohol cues and will explore the neural and behavioral mechanisms Methylphenidate not only improves sustained attention but in users of cocaine and methamphetamine it was previously shown to reduce craving attentional bias and neural responses to viewing drug-related cues Here we will use this commonly-prescribed medication as a pharmacological probe of attentional processes related to alcohol use disorder We hypothesize that acute methylphenidate-associated attentional enhancement will engage compensatory brain mechanisms that will lead to attenuated craving reduced attentional bias and modulated neural responses to alcohol cues in young adults with AUD and ADHD Thirty young adults with AUD and ADHD will be recruited for a double-blind placebo-controlled within-subjects experiment to test the effects of an acute 20 mg MPH administration to increase attention on cue-induced alcohol craving during simultaneous functional magnetic resonance imaging fMRI and EEG and attentional bias Subjects will also perform computerized tasks of general attention with non-alcohol-related stimuli The goal of this project is to support the design and funding proposal of a larger study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: None